New tool aims to help melanoma patients with autoimmune conditions navigate treatment decisions

NCT ID NCT04751396

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing an educational tool designed for people with melanoma who also have an autoimmune disease and are considering treatment with immune checkpoint inhibitors. Researchers want to see if the tool is easy to use and helpful for both patients and healthcare providers. About 125 participants will give feedback through interviews and surveys to improve the tool.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
educational tool
What this could lead to
If successful, this tool could help patients with melanoma and autoimmune diseases make more informed decisions about their treatment options.
What could go wrong
This is an early-stage study focused on usability, not on treatment outcomes. The tool may not improve decision-making or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.